A Phase I Study of Bevacizumab, Everolimus, and Panitumumab for Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Everolimus (Primary) ; Panitumumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 18 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Apr 2014 Planned End Date changed from 1 Nov 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 05 Apr 2013 Planned End Date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.